These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 14744536

  • 1. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.
    Himmelfarb M, Klopocki E, Grube S, Staub E, Klaman I, Hinzmann B, Kristiansen G, Rosenthal A, Dürst M, Dahl E.
    Cancer Lett; 2004 Feb 10; 204(1):69-77. PubMed ID: 14744536
    [Abstract] [Full Text] [Related]

  • 2. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J, Chorovicer M, Naami A, Breuer E, Zafrakas M, Bektas N, Dürst M, Kristiansen G, Wild PJ, Hartmann A, Knuechel R, Dahl E.
    Oncogene; 2008 Jan 31; 27(6):865-76. PubMed ID: 17653090
    [Abstract] [Full Text] [Related]

  • 3. [Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].
    Veeck J, Breuer E, Rose M, Chorovicer M, Naami A, Bektas N, Alkaya S, von Serényi S, Horn F, Hartmann A, Knüchel R, Dahl E.
    Pathologe; 2008 Nov 31; 29 Suppl 2():338-46. PubMed ID: 18810445
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inter-α-trypsin inhibitor heavy chain 5 (ITIH5) is overexpressed in inflammatory skin diseases and affects epidermal morphology in constitutive knockout mice and murine 3D skin models.
    Huth S, Heise R, Vetter-Kauczok CS, Skazik C, Marquardt Y, Czaja K, Knüchel R, Merk HF, Dahl E, Baron JM.
    Exp Dermatol; 2015 Sep 31; 24(9):663-8. PubMed ID: 25809190
    [Abstract] [Full Text] [Related]

  • 8. ITIH5 induces a shift in TGF-β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death.
    Rose M, Meurer SK, Kloten V, Weiskirchen R, Denecke B, Antonopoulos W, Deckert M, Knüchel R, Dahl E.
    Mol Carcinog; 2018 Feb 31; 57(2):167-181. PubMed ID: 28940371
    [Abstract] [Full Text] [Related]

  • 9. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
    Dötsch MM, Kloten V, Schlensog M, Heide T, Braunschweig T, Veeck J, Petersen I, Knüchel R, Dahl E.
    Epigenetics; 2015 Feb 31; 10(10):903-12. PubMed ID: 26252352
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer.
    Sasaki K, Kurahara H, Young ED, Natsugoe S, Ijichi A, Iwakuma T, Welch DR.
    Clin Exp Metastasis; 2017 Apr 31; 34(3-4):229-239. PubMed ID: 28289921
    [Abstract] [Full Text] [Related]

  • 13. ITIH5-Derived Polypeptides Covering the VIT Domain Suppress the Growth of Human Cancer Cells In Vitro.
    Rose M, Huth S, Wiesehöfer M, Ehling J, Henkel C, Steitz J, Lammers T, Kistermann J, Klaas O, Koch M, Rushrush S, Knüchel R, Dahl E.
    Cancers (Basel); 2022 Jan 19; 14(3):. PubMed ID: 35158755
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
    Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, Bertz S, Hartmann A, Karl A, Knüchel R, Dahl E.
    Carcinogenesis; 2014 Mar 19; 35(3):727-36. PubMed ID: 24265292
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum ITIH5 as a novel diagnostic biomarker in cholangiocarcinoma.
    Chen M, Ma J, Xie X, Su M, Zhao D.
    Cancer Sci; 2024 May 19; 115(5):1665-1679. PubMed ID: 38475675
    [Abstract] [Full Text] [Related]

  • 17. ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4.
    Liu J, Cao F, Li X, Zhang L, Liu Z, Li X, Lin J, Han C.
    Cell Death Dis; 2021 May 02; 12(5):438. PubMed ID: 33935281
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protein Z-dependent protease inhibitor (ZPI) is present in loco in human breast cancer tissue.
    Sierko E, Wojtukiewicz MZ, Ostrowska-Cichocka K, Zimnoch L.
    Thromb Haemost; 2010 Jul 02; 104(1):183-5. PubMed ID: 20458435
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.